AS
Therapeutic Areas
Crinetics Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Paltusotine (CRN00808) | Acromegaly | Phase 3 |
| CRN04777 | Congenital Hyperinsulinism | Phase 2 |
| CRN04894 | Cushing’s Disease | Phase 2 |
| CRN01941 | Neuroendocrine Tumors | Phase 1 |
Leadership Team at Crinetics Pharmaceuticals
RS
R. Scott Struthers, Ph.D.
Founder & Chief Executive Officer
SF
Stephen F. Betz, Ph.D.
Founder & Chief Scientific Officer
TS
Tobin Schilke
Chief Financial Officer
JK
Jeff Knight, M.P.H.
Chief Development & Operating Officer
IK
Isabel Kalofonos
Chief Commercial Officer
CR
Chris Robillard
Chief Business Officer
JK
Jacqueline Kirby
Chief Corporate Affairs Officer
GA
Garlan Adams, J.D.
Chief Legal Officer
AC
Adriana C. Cabré
Chief Human Resources Officer